Passaro A - Search Results

1

Multimodality treatment of gynecomastia in patients receiving antiandrogen therapy for prostate cancer in the era of abiraterone acetate and new antiandrogen molecules.

Alesini D, Iacovelli R, Palazzo A, Altavilla A, Risi E, Urbano F, Manai C, Passaro A, Magri V, Cortesi E. Alesini D, et al. Among authors: passaro a. Oncology. 2013;84(2):92-9. doi: 10.1159/000343821. Epub 2012 Nov 2. Oncology. 2013. PMID: 23128186 Review.

2

Second-line treatment of non-small-cell lung cancer: chemotherapy or tyrosine kinase inhibitors?

Passaro A, Cortesi E, de Marinis F. Passaro A, et al. Expert Rev Anticancer Ther. 2011 Oct;11(10):1587-97. doi: 10.1586/era.11.120. Expert Rev Anticancer Ther. 2011. PMID: 21999132 Review.

3

The impact of chemotherapy on the lymphatic system in thoracic oncology.

Passaro A, Trenta P, Conte D, Campennì G, De Benedetto A, Cortesi E. Passaro A, et al. Thorac Surg Clin. 2012 May;22(2):243-9. doi: 10.1016/j.thorsurg.2011.11.002. Epub 2011 Dec 29. Thorac Surg Clin. 2012. PMID: 22520292 Review.

4

Molecular and clinical analysis of predictive biomarkers in non-small-cell lung cancer.

Passaro A, Palazzo A, Trenta P, Mancini ML, Morano F, Cortesi E. Passaro A, et al. Curr Med Chem. 2012;19(22):3689-700. doi: 10.2174/092986712801661149. Curr Med Chem. 2012. PMID: 22680928 Review.

5

Erlotinib and gefitinib for elderly patients with advanced non-small-cell lung cancer.

Passaro A, Alesini D, Pochesci A, Cortesi E. Passaro A, et al. Anticancer Agents Med Chem. 2014 Jun;14(5):646-50. doi: 10.2174/187152061405140501101624. Anticancer Agents Med Chem. 2014. PMID: 23140355 Review.

6

Delivery optimization of erlotinib according to toxicity: may clinical practice go beyond research?

Passaro A, Fasano M, Bria E, Morgillo F, Cantile F, Alesini D, Pellegrino A, Cortesi E, Ciardiello F. Passaro A, et al. Lung Cancer. 2013 Jun;80(3):352-3. doi: 10.1016/j.lungcan.2013.01.023. Epub 2013 Feb 26. Lung Cancer. 2013. PMID: 23453130 No abstract available.

7

Neoadjuvant EGFR TKIs: toward personalized management in non-small-cell lung cancer.

Passaro A, Cortesi E. Passaro A, et al. Transl Lung Cancer Res. 2012 Dec;1(4):280-2. doi: 10.3978/j.issn.2218-6751.2012.09.11. Transl Lung Cancer Res. 2012. PMID: 25806194 Free PMC article. No abstract available.

8

Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies.

D'Antonio C, Passaro A, Gori B, Del Signore E, Migliorino MR, Ricciardi S, Fulvi A, de Marinis F. D'Antonio C, et al. Among authors: passaro a. Ther Adv Med Oncol. 2014 May;6(3):101-14. doi: 10.1177/1758834014521110. Ther Adv Med Oncol. 2014. PMID: 24790650 Free PMC article. Review.

9

Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non-small cell lung cancer.

Grossi F, Genova C, Crinò L, Delmonte A, Turci D, Signorelli D, Passaro A, Soto Parra H, Catino A, Landi L, Gelsomino F, Tiseo M, Puppo G, Roila F, Ricciardi S, Tonini G, Cognetti F, Toschi L, Tassinari D, Scoppola A, Giannarelli D, Cortesi E. Grossi F, et al. Among authors: passaro a. Eur J Cancer. 2019 Dec;123:72-80. doi: 10.1016/j.ejca.2019.09.011. Epub 2019 Oct 28. Eur J Cancer. 2019. PMID: 31671314

10

Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options.

Petrella F, Rizzo S, Attili I, Passaro A, Zilli T, Martucci F, Bonomo L, Del Grande F, Casiraghi M, De Marinis F, Spaggiari L. Petrella F, et al. Among authors: passaro a. Curr Oncol. 2023 Mar 7;30(3):3160-3175. doi: 10.3390/curroncol30030239. Curr Oncol. 2023. PMID: 36975452 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

330 results

Search Page